Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population

PURPOSE: ATTRACTION-2 trial assessed the role of Nivolumab as a new standard treatment for Asian patients with pretreated metastatic gastric cancer (mGC). The aim of this analysis was to evaluate the safety and efficacy of Nivolumab in a real-life Western population, considering the lack of evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrillo, Angelica, Tirino, Giuseppe, Zito Marino, Federica, Pompella, Luca, Sabetta, Rosalaura, Panarese, Iacopo, Pappalardo, Annalisa, Caterino, Marianna, Ventriglia, Anna, Laterza, Maria Maddalena, Morgillo, Floriana, Orditura, Michele, Ciardiello, Fortunato, Franco, Renato, De Vita, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996223/
https://www.ncbi.nlm.nih.gov/pubmed/32099391
http://dx.doi.org/10.2147/OTT.S229813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996223/
https://www.ncbi.nlm.nih.gov/pubmed/32099391
http://dx.doi.org/10.2147/OTT.S229813

Ejemplares similares